ArticlePulmonary circulation2025

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.

James R Klinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.